Recombinant Human TAGLN/Transgelin protein is a Human Full Length protein, in the 1 to 201 aa range, expressed in Escherichia coli, with >85% purity and suitable for SDS-PAGE, MS, WB.
M G S S H H H H H H S S G L V P R G S H M A N K G P S Y G M S R E V Q S K I E K K Y D E E L E E R L V E W I I V Q C G P D V G R P D R G R L G F Q V W L K N G V I L S K L V N S L Y P D G S K P V K V P E N P P S M V F K Q M E Q V A Q F L K A A E D Y G V I K T D M F Q T V D L F E G K D M A A V Q R T L M A L G S L A V T K N D G H Y R G D P N W F M K K A Q E H K R E F T E S Q L Q E G K H V I G L Q M G S N R G A S Q A G M T G Y G R P R Q I I S
Application | Reactivity | Dilution info | Notes |
---|---|---|---|
Application SDS-PAGE | Reactivity Reacts | Dilution info - | Notes - |
Application MS | Reactivity Reacts | Dilution info - | Notes - |
Application WB | Reactivity Reacts | Dilution info - | Notes ab101469 can be used as a WB positive control in conjunction with Anti-TAGLN/Transgelin antibody ab14106. |
Actin cross-linking/gelling protein (By similarity). Involved in calcium interactions and contractile properties of the cell that may contribute to replicative senescence.
SM22, WS3-10, TAGLN, Transgelin, 22 kDa actin-binding protein, Protein WS3-10, Smooth muscle protein 22-alpha, SM22-alpha
Recombinant Human TAGLN/Transgelin protein is a Human Full Length protein, in the 1 to 201 aa range, expressed in Escherichia coli, with >85% purity and suitable for SDS-PAGE, MS, WB.
pH: 8
Constituents: 20% Glycerol (glycerin, glycerine), 0.316% Tris HCl, 0.0154% (R*,R*)-1,4-Dimercaptobutan-2,3-diol
ab101469 was purified using conventional chromatography techniques.
Actin cross-linking/gelling protein (By similarity). Involved in calcium interactions and contractile properties of the cell that may contribute to replicative senescence.
Belongs to the calponin family.
This product was previously labelled as TAGLN
TAGLN also known as Transgelin or SM22-alpha is a protein with a molecular weight of approximately 22 kDa. Structurally it belongs to the calponin family and contains an ACT domain which is critical for its actin-binding ability. It is expressed abundantly in smooth muscle cells where it stabilizes cytoskeletal dynamics by interacting with actin filaments. TAGLN also shows expression in fibroblasts and myofibroblasts supporting structural integrity and cellular movement.
The regulatory involvement of TAGLN in smooth muscle contraction influences cellular activities essential for vascular function. This protein modulates remodeling and differentiation within smooth muscle cells. It can associate with actin and calponin to form complexes that regulate the stability of cytoskeletal structures ensuring effective cellular responses to mechanical stimuli. By linking signal transduction to cytoskeletal mechanics TAGLN facilitates the maintenance of cell shape and tension.
TAGLN plays a role in the regulation of the RhoA/Rho kinase pathway contributing to actin cytoskeleton organization and smooth muscle contraction. Additionally it is involved in the WNT signaling pathway influencing cell proliferation and differentiation. In these pathways TAGLN works with proteins like RhoA and beta-catenin to transmit signals from the extracellular environment to the nucleus impacting gene expression and cellular responses.
Disruptions in TAGLN expression associate with vascular diseases and certain cancers. Downregulation or altered expression patterns can lead to smooth muscle cell dysfunction contributing to atherosclerosis. Similarly TAGLN interacts with proteins such as fibronectin and MMP2 in cancer where its altered expression could promote metastasis and tumor progression. Understanding these connections highlights TAGLN's potential as a target for therapeutic interventions in these diseases.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
All lanes: Western blot - Anti-TAGLN/Transgelin antibody (Anti-TAGLN/Transgelin antibody ab14106) at 1 µg/mL
Lane 1: Western blot - Recombinant Human TAGLN/Transgelin protein (ab101469) at 0.01 µg
Lane 1: Western blot - Recombinant Human SPG21/Maspardin protein (Recombinant Human SPG21/Maspardin protein ab86438)
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) preadsorbed (Goat Anti-Rabbit IgG H&L (HRP) preadsorbed ab97080) at 1/5000 dilution
Developed using the ECL technique.
Performed under reducing conditions.
Predicted band size: 23 kDa, 35 kDa
Exposure time: 30s
SDS-PAGE analysis of ab101469 (3µg).
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com